Can a Natriuretic Peptide Blood Test Identify Cardiac Syncope in the ER? | Research

The takeaway

Pro-BNP blood levels had 94.7% sensitivity for identifying cardiac causes of fainting, making it a useful screening tool in emergency departments.

94.7% sensitivity
Pro-BNP correctly identified nearly all cardiac syncope cases, making it a strong screening tool for ruling out cardiac causes of fainting

What the researchers found

Pro-BNP demonstrated 94.73% sensitivity and 56.79% specificity for diagnosing cardiac syncope. Higher Pro-BNP levels correlated with age, longer hospitalization, and ECG abnormalities. As an independent marker, Pro-BNP showed acceptable diagnostic performance for identifying cardiac causes of syncope in the emergency department.

Why it matters

Quickly identifying whether fainting has a cardiac cause is critical in emergency medicine — cardiac syncope can signal life-threatening conditions. A simple blood test measuring the natriuretic peptide Pro-BNP could help ER doctors rapidly triage syncope patients, though its moderate specificity means additional testing is still needed.

The numbers in context

Not specified in abstract — analytical cross-sectional design with initial evaluations including history, physical exam, ECG, and blood sugar.

How the study worked

Analytical cross-sectional study of 100 patients presenting with syncope. Patients underwent standard evaluation including history, physical exam, ECG, blood sugar, and as needed, brain CT, echocardiography, and CTA. Pro-BNP levels were measured and correlated with final diagnosis of cardiac vs. non-cardiac syncope.

Who was studied

Emergency department patients presenting with syncope

What this study cannot tell us

Small sample of only 100 patients at a single center. Cross-sectional design limits causal conclusions. Low specificity (56.8%) means many non-cardiac patients would have elevated Pro-BNP, requiring additional testing. No comparison with other biomarkers or scoring systems for syncope evaluation.

How to read the evidence

Rated moderate: single-center cross-sectional study with 100 patients. Adequate for exploratory diagnostic accuracy but needs larger validation studies.

When this study was published

Published in 2024. Adds to growing literature on natriuretic peptides as diagnostic biomarkers beyond heart failure.

The bigger picture

Natriuretic peptides like BNP and Pro-BNP are increasingly recognized as valuable biomarkers beyond heart failure diagnosis. Their potential to screen for cardiac syncope adds another clinical application for these peptide-based tests.

Questions still open

Would combining Pro-BNP with other markers improve specificity for cardiac syncope?
What is the optimal Pro-BNP cutoff value for syncope screening?
Does Pro-BNP also predict which cardiac syncope patients need urgent intervention?

Common questions

What is Pro-BNP?

Pro-brain natriuretic peptide (Pro-BNP) is a protein fragment released by heart muscle cells under stress. It's commonly measured via a blood test to help diagnose heart conditions.

Can a blood test tell if fainting is from a heart problem?

This study found Pro-BNP blood levels caught 94.7% of cardiac syncope cases, though about half of non-cardiac patients also had elevated levels, so additional testing is still needed.

Read the original research

Serum Levels of Pro-Brain Natriuretic Peptide and the Diagnosis and Prognosis of Cardiac Syncope.

Bulletin of emergency and trauma, 12(3), 130-135

View on PubMed ↗Publisher’s paper ↗

Citation

Sadrzadeh, Sayyed Majid; Shahri, Bahram; Kamandi, Mostafa; Adimolmasali, Maryam; Rezvani Kakhki, Behrang; Feiz Disfani, Hamideh. (2024). Serum Levels of Pro-Brain Natriuretic Peptide and the Diagnosis and Prognosis of Cardiac Syncope.. Bulletin of emergency and trauma, 12(3), 130-135. https://doi.org/10.30476/beat.2024.103126.1520